Capital Sum (Dismemberment Benefit)

Capital Sum (Dismemberment Benefit) is a type of insurance benefit that provides a lump sum payment to the insured or their beneficiaries in the event of a loss of limb or other dismemberment resulting from an accident. The payment amount is usually specified in the insurance policy and is based on the severity of the dismemberment.

Here are some key features of Capital Sum (Dismemberment Benefit):

  • Capital Sum (Dismemberment Benefit) is a type of insurance benefit that provides a lump sum payment in the event of a loss of limb or other dismemberment resulting from an accident.

  • The payment amount is usually specified in the insurance policy and is based on the severity of the dismemberment.

  • Capital Sum (Dismemberment Benefit) is often included as a rider to a life insurance policy, but it can also be purchased as a standalone policy.

  • The benefit is paid to the insured or their beneficiaries, depending on the terms of the policy.

  • The benefit is typically paid in addition to any other benefits the insured may be entitled to under the policy.

For example, let's say that John has a Capital Sum (Dismemberment Benefit) rider on his life insurance policy with a specified benefit amount of $50,000. If John loses his leg in a car accident, he would be entitled to the $50,000 payment from the insurance company. The benefit would be paid in addition to any other benefits he may be entitled to under the policy, such as a death benefit.

In summary, Capital Sum (Dismemberment Benefit) is a type of insurance benefit that provides a lump sum payment in the event of a loss of limb or other dismemberment resulting from an accident. The payment amount is usually specified in the insurance policy and is paid to the insured or their beneficiaries, depending on the terms of the policy.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.